Earlier in Asia, Chinese markets dropped down after the communist leaders in China, the world’s second-biggest economy, lowered their growth forecast to about 7%, down from 7.5 percent last year. The new official benchmark comes after China’s economy expanded 7.4 percent in 2014, its slowest pace in nearly a quarter century.
Insights about U.S. Stocks that are active during the current trade, are depicted underneath:
Gilead Sciences, Inc (NASDAQ:GILD)’s shares picked up 0.38%, and is now trading at $103.44. The Stock is active as 3.79M shares changed hands versus its average volume of 12.86M shares.
Formerly on February 26, Gilead Sciences Inc. (GILD), declared detailed 48-week results from two Phase 3 studies (Studies 104 and 111) evaluating its investigational once-daily single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults. A regimen of elvitegravir 150 mg, cobicistat 150 mg, emtricitabine 200 mg and TAF 10 mg (E/C/F/TAF) was found to be statistically non-inferior to Gilead’s Stribild® (containing elvitegravir 150 mg, cobicistat 150 mg, emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg), based on percentages of patients with HIV-1 RNA levels less than 50 copies/mL. A second analysis found that patients receiving the TAF regimen also had significantly better renal and bone laboratory parameters than those treated with Stribild. The data were presented in two late-breaker presentations (Sessions O-10 and O-11) at the 22nd Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle.
TAF is a novel nucleotide reverse transcriptase inhibitor (NRTI) that has demonstrated high antiviral efficacy at a dose 10 times lower than Gilead’s Viread® (tenofovir disoproxil fumarate, TDF), as well as improved renal and bone laboratory parameters in clinical trials.
“Long-term renal and bone health have been ongoing concerns, especially as people with HIV live longer and remain on antiretroviral treatment for greater periods of time,” said Paul Sax, MD, a Clinical Director at Brigham and Women’s Hospital, Professor of Medicine at Harvard Medical School and the lead researcher of the E/C/F/TAF safety analysis. “These results show that a TAF-based single tablet regimen has the potential to assist address the needs of appropriate HIV patients facing life-long antiretroviral therapy.”
Gilead Sciences is a biopharmaceutical corporation that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The corporation’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.
Oracle Corporation (NYSE:ORCL), raised 0.39%, and is now trading at $43.78. The Stock is active as 4.37M shares changed hands versus its average volume of 12.58M shares.
Demonstrating its continued investment in the world’s #1 programming language, Oracle Corporation (ORCL), declared the release of the Java Development Kit (JDK) 8, Update 40 (JDK 8u40). From small devices to smart cities, Java powers solutions like no other technology. As such, Oracle is committed to working closely with key partners in the Java ecosystem to continually modernize and deliver new innovations to the Java Platform. This latest release of Oracle’s implementation of Java SE, JDK 8u40, brings improvements to performance, scalability and administration, making it easier for Java developers, partners and IT decision makers to innovate faster in a simple, easy manner and improve application services. The release also comprises new updates to JavaFX.
“The proliferation of mobile devices and the Internet of Things has led to an increasingly connected world, but none of this would be possible without underlying foundational technology like Java,” said Georges Saab, vice president of development, Java Platform at Oracle. “With these updates to JDK 8, we continue to usher in the next era of Java to enable developers and enterprises alike to cement Java’s role as the backbone of today’s and tomorrow’s revolutionary business solutions.”
Oracle Corporation develops, manufactures, markets, hosts, and supports database and middleware software, application software, cloud infrastructure, hardware systems, and related services worldwide.
Darling Ingredients Inc (NYSE:DAR), declined -6.50%, and is now trading at $16.10, hitting new 52-week low of $15.74. The Stock is active as 6.42M shares changed hands versus its average volume of 2.16M shares.
Darling Ingredients Inc. (DAR), a global developer and producer of sustainable natural ingredients from edible and inedible bio-nutrients, creating a wide range of ingredients and customized specialty solutions for customers in the pharmaceutical, food, pet food, feed, technical, fuel, bioenergy, and fertilizer industries, stated financial results for the fourth quarter and fiscal year ended January 3, 2015.
Net sales for the fourth quarter of 2014 raised to $1.0 billion, contrast with $447.9 million in the same period of 2013, attributable to newly attained operations in first quarter of 2014. Operating revenue in the fourth quarter of 2014 was $39.7 million, contrast with $18.5 million for the same period of 2013.
“Our business continued to experience headwinds in fourth quarter 2014 from globally lower prices for our finished products and a stronger U.S. dollar. The global price resetting appears to have stabilized with raw material values adjusting and prices for most proteins recovering to meet the raised demand in both the feed and pet food sectors. Fat and used cooking oil finished product prices continued their decline as a result of larger global grain supplies, lower crude oil values, and a non-defined Renewable Fuel Standard for 2014 or 2015. Diamond Green Diesel delivered a tremendous quarter, and as anticipated we benefited from the reinstatement of the biodiesel blender’s tax credit,” said Randall Stuewe, Darling Ingredients Inc. Chairman and Chief Executive Officer.
Fourth quarter 2014 net revenue attributable to Darling was $69.9 million, or $0.42 per diluted share, contrast with net revenue of $22.5 million, or $0.18 per diluted share, in the fourth quarter of 2013. For the fourth quarter of fiscal 2014, the Corporation generated Adjusted EBITDA of $108.7 million, as contrast to $50.2 million in the same period in 2013. The raise was primarily attributable to the inclusion of the blender’s tax credit from the DGD Joint Venture and our newly attained operations. On a Pro Forma Adjusted EBITDA basis, the Corporation would have generated $111.1 million in the fourth quarter 2014, as contrast to a Pro Forma Adjusted EBITDA of $64.4 million in the same period in 2013.
Darling Ingredients Inc. is the world’s largest publicly-traded developer and producer of sustainable natural ingredients from edible and inedible bio-nutrients, creating a wide range of ingredients and customized specialty solutions for customers in the pharmaceutical, food, pet food, feed, technical, fuel, bioenergy and fertilizer industries.
Verizon Communications Inc (NYSE:VZ), dipped -0.18%, and is now trading at $48.98. The Stock is active as 3.68M shares changed hands versus its average volume of 18.80M shares.
Taking in episodes of Russian spies hidden in plain sight, plotting at Paddy’s Pub and roaring polar bears is no longer limited to in-home viewing. Verizon FiOS TV customers now have even more to watch with five Fox channels accessible on the FiOS Mobile App, which customers are using more and more in the home and on the go.
The addition of the networks — FX, FXX, FXM, Nat Geo WILD and National Geographic Channel — raises to 93 the number of live, outside the home channels accessible on virtually any device. TV consumption across devices grew 388 percent year over year, according to Adobe Digital Index 2014.
FiOS TV customers who have the free FiOS Mobile App can now access these channels to watch live popular shows such as FX’s “The Americans,” and National Geographic Channel’s “Brain Games,” or tune-in to hit comedies counting FXX’s “It’s Always Sunny in Philadelphia,” outside the home. FiOS TV customers can presently watch FX, FXX, FXM, National Geographic Channel and Nat Geo WILD within the home through the FiOS Mobile app.
Verizon Communications Inc., through its auxiliaries, provides communications, information, and entertainment products and services to consumers, businesses, and governmental agencies worldwide.
